真核表达系统,动物细胞内正确折叠,避免体外复性重折叠
可提供FITC/PE/APC/Alexa Fluor/Biotin等多种标记类型
单体/四聚体可供选择
异源二聚体共表达,更接近天然构象,可被W6/32抗体正确识别
全面的生物活性验证方法:SPR/ELISA/FACS等
专业的MHC-多肽复合物开发平台
早期发现
CMC工艺生产质控
临床&临床前研究
MHC Allele | |||||||
---|---|---|---|---|---|---|---|
Human classical MHC class I | Human classical MHC II | Mouse | Monkey | ||||
HLA-A*01:01HLA-A*02:01HLA-A*02:06HLA-A*03:01HLA-A*11:01HLA-A*24:02HLA-A*26:01HLA-A*30:01HLA-A*33:03 | HLA-B*07:02HLA-B*08:01HLA-B*15:01HLA-B*15:02HLA-B*27:05HLA-B*40:01HLA-B*57:01 | HLA-C*03:03HLA-C*03:04HLA-C*07:02:01HLA-C*08:01 | HLA-E*01:03 |
HLA-DQA1*03:02 &DQB1*03:03 HLA-DRA1*01:01 &HLA-DRB1*04:01 HLA-DRA1*01:01 &HLA-DRB1*11:01 HLA-DRA1*01:01 &HLA-DRB1*15:01 |
H-2DbH-2KbH-2Kd | Mamu-A*01Mamu-A*08 | 更多基因型仍在开发中,如果您感兴趣的基因型未列出,请与我们联系。 |
5e5 of anti-NY-ESO-1 TCR-293 cells were stained with 100 μL of 1:25 dilution (4 μL stock solution in 100 μL FACS buffer) of PE-Labeled Human HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQC) Tetramer Protein (Cat. No. HL1-HP2E5) and negative control protein respectively. PE signal was used to evaluate the binding activity (QC tested).
申请 Protocol
5e5 of anti-NY-ESO-1 TCR-293 cells were stained with 100 μL of 1:25 dilution (4 μL stock solution in 100 μL FACS buffer) of PE-Labeled Human HLA-A0201&B2M&NY-ESO-1 (SLLMWITQV) Tetramer Protein (Cat. No. HL1-HP2E6) and negative control protein respectively. PE signal was used to evaluate the binding activity (QC tested).
申请 Protocol
Performance of PE-labeled Human HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQC) Tetramer from ACROBiosystems (Cat. No. HL1-HP2E5) and other brand were evaluated by flow cytometry under the manufacturer’s recommended conditions. ACROBiosystems’ PE-Labeled NY-ESO-1 Tetramer Protein shows 3x higher MFI signal strength than competitor M, revealing much better TCR binding.
Performance of PE-labeled Human HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQV) Tetramer from ACROBiosystems (Cat. No. HL1-HP2E6) and other brand were evaluated by flow cytometry under the manufacturer’s recommended conditions. ACROBiosystems’ PE-Labeled NY-ESO-1 Tetramer Protein shows 2x higher MFI signal strength than competitor M, revealing much better TCR binding.
Immobilized Biotinylated Human HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQC) Complex Protein (Cat. No. HL1-H82E6) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Anti-NY-ESO-1 Antibody, Human IgG1 with a linear range of 0.1-8 ng/mL (QC tested).
申请 Protocol
Immobilized Biotinylated Human HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQC) Complex Protein (Cat. No. HL1-H82E6) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Anti-HLA class I Antibody, Human IgG1 (W6/32) with a linear range of 0.1-1 ng/mL (Routinely tested).
申请 Protocol
Anti-HLA class I Antibody, Human IgG1 (W6/32) captured on Protein A Chip can bind Human HLA-A*11:01&B2M&KRASG12D (VVGADGVGK) Complex Protein (Cat. No. HLD-H52H4) with an affinity constant of 1.06 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
申请 Protocol
1.Thomas C, Tampé R. MHC I assembly and peptide editing - chaperones, clients, and molecular plasticity in immunity. Curr Opin Immunol. 2021 Jun;70:48-56. doi: 10.1016/j.coi.2021.02.004. Epub 2021 Mar 6. PMID: 33689959.
2.Becar M, Kasi A. Physiology, MHC Class I. 2021 Sep 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 32310482.